Rosen Law Firm reminds purchasers of Embecta Corp. common stock between November 25, 2025 and May 4, 2026 of the August 17, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges that Embecta made false or misleading statements about its fiscal results and guidance, including touting its pen needle business as "incredibly resolute" shortly before missing expectations and cutting fiscal 2026 guidance. Investors who bought shares during the class period may be entitled to compensation through a contingency fee arrangement without out-of-pocket costs. A class has not yet been certified, and investors may choose their own counsel or remain absent class members.
Embecta CorpSecurities class action lawsuit alleging false statements about fiscal results and guidance.